Our western blot analysis revealed that XYKJP significantly suppressed JAK2 and STAT3 phosphorylation (Fig. 6C), suggesting that XYKJP's potential therapeutic effects on colitis may be mediated through the inhibition of the JAK2/STAT3 pathway. The gene discussed is STAT3; the disease is colitis.